Home Business Zydus Cadila gets final approval from USFDA to market Potassium Chloride Capsules

Zydus Cadila gets final approval from USFDA to market Potassium Chloride Capsules

By
Dhrumit Thakkar
-
441
0
(G.N.S) Dt. 15 Ahmedabad Giving out an approval USFDA has sent final approval to Zydus Cadila to market Potassium Chloride Extended-Release Capsules USP, 8 mEq (600 mg) and 10 mEq (750 mg). A capsule Potassium Chloride Extended-Release Capsules USP, 8 mEq (600 mg) and 10 mEq (750 mg) It will

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In
   
New User Registration
*Required field

RELATED ARTICLESMORE FROM AUTHOR